Boobalan Pachaiyappan
Managing Director, Senior Biotech Analyst,
Roth Capital Partners
Boobalan Pachaiyappan, Ph. D., is a Managing Director and Senior Biotech Analyst at Roth Capital Partners. At Roth, he focuses on the firm's SMID-cap coverage of emerging growth companies in the pharma/biotech sector, with a predilection towards neurology, neuropsychiatry, neuromuscular disorders, respiratory diseases and pain. Prior to Roth, Boobalan worked at H.C. Wainwright, where he held roles of increasing responsibilities, including Director. Boobalan was awarded a Ph.D. in Medicinal Chemistry (University of Illinois at Chicago) and did postdoctoral fellowships in multiple institutions, including Northwestern University.
Sessions
-
11-Feb-2025AstorTackling Mental Health through New Targets and Endpoints Progress
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
)
){kind=logo}
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}
){kind=logo}